Vancouver Area Network of Drug Users

Partial victory on Immigration and HIV/AIDS; Join the AIDSPOLICYLAW-list listserv; Injection drug use and HIV/AIDS; The Network has moved; Network starts community-based research project entitled "Healthy Public Policy"; Evaluation demonstrates impact of Network's work; Comments and feedback from program evaluation interviews; Project on Global Access to Treatment; Network Staff and Board; Important dates - upcoming HIV/AIDS skills-building workshop in Montreal; conference on Critical Legal Issues and HIV/AIDS in Barcelona; New network resources and documents

Newsletter with articles entitled: Pivot's Housing Affidavit Campaign Kicks Off; Hope in the Shadows Calendar - Photo Contest Success; Pivot Events; Campaign News: Sex Work Report, Small Claims Booklet, Legal Co-op, and booth team increases visibility; RCMP Report: To serve and protect (who?); Pivot Staff and Directors - Who's Who?; Be a Pivot Partner; 10 Reasons to Support Pivot.

Policy analysis on the possible establishment and maintenance of safe injection rooms in Vancouver's Downtown Eastside. Interviews were conducted with community organizations and stakeholders working in the area of drug addiction. Community objectives for safe injection rooms included enhancing the social environment of the DTES; maximizing community health; maximizing community safety; ensuring economic viability in the DTES; and minimizing costs to the public. Stakeholders preferred a Community-Driven Model for a safe injection room program. This model, and its alternatives, are discussed, in terms of how they could be implemented in the DTES environment. A copy of the interview questions used with stakeholders, and a breakdown of each stakeholder's responses, is included with the document.

Brochure describing in plain language the results of the first large-scale HIV/AIDS vaccine research study (the AIDSVAX trial). It was created due to public confusion about the meaning of the results. It explains that the vaccine did not work. It describes the research study, in terms of how AIDSVAX was tested; who were the trial volunteers; future AIDSVAX research; and new types of vaccines currently under development.